tolvaptan
Drug timelines are a Plus or Pro feature.
63 regulatory and trial events tracked for tolvaptan, covering 2010-03-11 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) [Phase 3]